Charles Schwab
SQZ

Charles Schwab’s SQZ Biotechnologies Company SQZ Stock Holding History

Charles Schwab’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-60,693
Closed -$292K – 3689
2022
Q1 		$292K Buy
60,693
+4,196
+7% +$26.6K ﹤0.01% 3220
2021
Q4 		$505K Buy
56,497
+317
+0.6% +$3.89K ﹤0.01% 3142
2021
Q3 		$811K Sell
56,180
-27,266
-33% -$370K ﹤0.01% 2951
2021
Q2 		$1.21M Buy
83,446
+37,832
+83% +$494K ﹤0.01% 2864
2021
Q1 		$624K Buy
45,614
+20,612
+82% +$419K ﹤0.01% 3016
2020
Q4 		$725K Buy
+25,002
New +$638K ﹤0.01% 2874

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab's SQZ Position: Q2 2022 in Review

Charles Schwab sold out of SQZ Biotechnologies Company (SQZ) in Q2 2022, closing a stake of 60,693 shares — an estimated $292K sold.

Charles Schwab first reported a position in SQZ in Q4 2020 and held it in 6 quarters. The position peaked at $1.21M in Q2 2021. 53 funds tracked by Wall St. Rank hold SQZ as of Q2 2022.

  • Charles Schwab reported no remaining SQZ Biotechnologies Company position as of Q2 2022 after selling out during the quarter.
  • Charles Schwab sold 60,693 SQZ Biotechnologies Company shares in Q2 2022, an estimated $292K.
  • Charles Schwab first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 6 quarters.
  • Charles Schwab's SQZ Biotechnologies Company position peaked at $1.21M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2022.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.